SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-012720
Filing Date
2020-11-05
Accepted
2020-11-05 08:06:59
Documents
65
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ardx-20200930x10q.htm   iXBRL 10-Q 1993909
2 EX-31.1 ardx-20200930xex31d1.htm EX-31.1 15522
3 EX-31.2 ardx-20200930xex31d2.htm EX-31.2 15528
4 EX-32.1 ardx-20200930xex32d1.htm EX-32.1 12034
  Complete submission text file 0001558370-20-012720.txt   6615096

Data Files

Seq Description Document Type Size
5 EX-101.SCH ardx-20200930.xsd EX-101.SCH 47120
6 EX-101.CAL ardx-20200930_cal.xml EX-101.CAL 50032
7 EX-101.DEF ardx-20200930_def.xml EX-101.DEF 143218
8 EX-101.LAB ardx-20200930_lab.xml EX-101.LAB 346728
9 EX-101.PRE ardx-20200930_pre.xml EX-101.PRE 282657
10 EXTRACTED XBRL INSTANCE DOCUMENT ardx-20200930x10q_htm.xml XML 1150263
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36485 | Film No.: 201288790
SIC: 2834 Pharmaceutical Preparations